Your browser doesn't support javascript.
loading
Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.
Bleakley, Marie; Heimfeld, Shelly; Jones, Lori A; Turtle, Cameron; Krause, Diane; Riddell, Stanley R; Shlomchik, Warren.
Afiliação
  • Bleakley M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington. Electronic address: mbleakle@fhcrc.org.
  • Heimfeld S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Jones LA; Seattle Cancer Care Alliance, Seattle, Washington.
  • Turtle C; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
  • Krause D; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
  • Shlomchik W; Department of Hematology, Yale School of Medicine, New Haven, Connecticut.
Biol Blood Marrow Transplant ; 20(5): 705-16, 2014 May.
Article em En | MEDLINE | ID: mdl-24525279
ABSTRACT
Graft-versus-host disease (GVHD) is a frequent major complication of allogeneic hematopoietic cell transplantation (HCT). Approaches that selectively deplete T cells that cause GVHD from allogeneic stem cell grafts and preserve T cells specific for pathogens may improve HCT outcomes. It has been hypothesized that the majority of T cells that can cause GVHD reside within the naïve T cell (TN) subset, and previous studies performed in mouse models and with human cells in vitro support this hypothesis. As a prelude to translating these findings to the clinic, we developed and evaluated a novel 2-step clinically compliant procedure for manipulating peripheral blood stem cells (PBSC) to remove TN, preserve CD34(+) hematopoietic stem cells, and provide for a fixed dose of memory T cells (TM) that includes T cells with specificity for common opportunistic pathogens encountered after HCT. Our studies demonstrate effective and reproducible performance of the immunomagnetic cell selection procedure for depleting TN. Moreover, after cell processing, the CD45RA-depleted PBSC products are enriched for CD4(+) and CD8(+) TM with a central memory phenotype and contain TM cells that are capable of proliferating and producing effector cytokines in response to opportunistic pathogens.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Subpopulações de Linfócitos T / Engenharia Tecidual / Memória Imunológica / Antígenos Virais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Subpopulações de Linfócitos T / Engenharia Tecidual / Memória Imunológica / Antígenos Virais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article